Since the Korea's first urolithiasis treatment "UROCITRA" in 1999, we have made every effort to be a leading maker in the field of urologic medicines. As a result, we have marketed "UROCITRA" and another urolithiasis treatment "ROWATINEX" successfully. Moreover, we have developed and supplied "ROWACHOL" for cholelithiasis treatments and "HEPADIAL" for dyspepsia symptom of the patients with hepato-biliary diseases.

For more information about our products, please feel free to
contact us at any time.

Thank you